Uterine Cervical Cancer, Uterine Corpus Cancer
Conditions
Interventions
sentinel lymph node biopsy
Sponsors
Abiko Kaoru
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Patients diagnosed with cervical cancer or endometrial cancer at the Department of Obstetrics and Gynecology of our hospital between the date of iRCT publication and March 31, 2027, who are scheduled to undergo surgical treatment. Age over 20 years at the time of informed consent. Written informed consent was obtained from the patient for participation in the study.
Exclusion criteria
Exclusion criteria: Patients in whom preoperative imaging suggests lymph node metastasis. Patients who have received prior treatment such as radiotherapy or chemotherapy before surgery. Patients with a history of hypersensitivity to indocyanine green or iodinated contrast agents. Patients deemed otherwise inappropriate for inclusion in the study at the discretion of the attending physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of Safety Related to the Examination/Procedure Complications to be monitored include anaphylaxis, vascular or nerve injury, and other adverse events commonly associated with surgical treatment for malignant tumors in routine clinical practice. | — |
Contacts
Public ContactTakashi IIZUKA
Kanazawa University Hospital
Outcome results
None listed